Hisashi Imaichi

Pharmacological effects of TAK-828F: an orally available RORγt inverse agonist, in mouse colitis model and human blood cells of inflammatory bowel disease

T. Kanai, S. Mizuno, N. Tsuchimori, 2019, Inflammation Research.

A small-molecule SUMOylation inhibitor activates antitumor immune responses and potentiates immune therapies in preclinical models

Steven S. Langston, Xingyue He, E. Lightcap, 2021, Science Translational Medicine.

Pharmacological effects of TAK-828F: an orally available RORγt inverse agonist, in mouse colitis model and human blood cells of inflammatory bowel disease

T. Kanai, S. Mizuno, N. Tsuchimori, 2019, Inflammation Research.